Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Search Results

407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart AM, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrián N, Barba P, Kwon M, Lopez-Corral L, Martinez-Lopez J, Ferra C, Di Blasi R, Ghesquieres H, Mutsaers P, Calkoen F, Jak M, van Doesum J, Vermaat JSP, van der Poel M, Maertens J, Gambella M, Metafuni E, Ciceri F, Saccardi R, Nicholson E, Tholouli E, Matthew C, Potter V, Bloor A, Besley C, Roddie C, Wilson K, Nagler A, Campos A, Petersen SL, Folber F, Bader P, Finke J, Kroger N, Knelange N, de La Camara R, Kersten MJ, Mielke S. Spanjaart AM, et al. Among authors: kersten mj. Leukemia. 2024 Jul 23. doi: 10.1038/s41375-024-02336-1. Online ahead of print. Leukemia. 2024. PMID: 39043963
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
van Meerten T, Kuruvilla J, Song KW, Thieblemont C, Minnema MC, Forcade E, De Guibert S, Kersten MJ, Mutsaers PG, Wermke M, Zheng Y, Xue A, Winters JN, Nater J, Shen RR, Spooner C, Neumann F, Kim JJ, Topp MS. van Meerten T, et al. Among authors: kersten mj. Am J Cancer Res. 2024 Jun 15;14(6):2905-2920. doi: 10.62347/LLXR8002. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005691 Free PMC article.
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T-cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma.
De Jonge AV, Bruins WSC, Duetz C, Korst CLBM, Rentenaar R, Cosovic M, Eken M, Kersten MJ, Sandberg Y, Van Rijn RS, Fijnheer R, Mutsaers P, Vergote VKJ, Issa D, Beeker A, Bilgin YM, Visser O, Van Werkhoven E, Roemer MGM, Chamuleau MED, Mutis T. De Jonge AV, et al. Among authors: kersten mj. Haematologica. 2024 Jul 4. doi: 10.3324/haematol.2024.285170. Online ahead of print. Haematologica. 2024. PMID: 38961740 Free article.
para-Aminoazobenzenes-Bipolar Redox-Active Molecules.
Schatz D, Baumert ME, Kersten MC, Schneider FM, Nielsen MB, Hansmann MM, Wegner HA. Schatz D, et al. Among authors: kersten mc. Angew Chem Int Ed Engl. 2024 Jun 13:e202405618. doi: 10.1002/anie.202405618. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38869230
A Robust SARS-CoV-2-specific T and B Cell Response is Associated with Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Vergouwe M, Biemond JJ, van der Straten K, van Pul L, Kerster G, Claireaux M, Burger JA, van Dort KA, Kootstra NA, Jonges M, Welkers MRA, Hazenberg MD, Peters-Sengers H, van Gils MJ, Wiersinga WJ, Birnie E, de Bree GJ; TURN-COVID study group. Vergouwe M, et al. J Infect Dis. 2024 Jun 6:jiae306. doi: 10.1093/infdis/jiae306. Online ahead of print. J Infect Dis. 2024. PMID: 38843052
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Brink M, Huisman F, Meeuwes FO, van der Poel MWM, Kersten MJ, Wondergem M, Böhmer L, Woei-A-Jin FJSH, Visser O, Oostvogels R, Jansen PM, Diepstra A, Snijders TJF, Huls G, Vermaat JSP, Plattel WJ, Nijland M. Brink M, et al. Among authors: kersten mj. Blood Adv. 2024 Jul 23;8(14):3619-3628. doi: 10.1182/bloodadvances.2023012531. Blood Adv. 2024. PMID: 38739705 Free PMC article.
407 results